Loading…
Pasithea Therapeutics Corp. is projected to rise to $0.7698 by 2027, a +11% move from its current price of $0.6929. KTTA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.6695 | $0.6931 | $0.7176 | +0.03% |
| May 30 | $0.6602 | $0.6934 | $0.7282 | +0.07% |
| May 31 | $0.6532 | $0.6936 | $0.7365 | +0.10% |
| Jun 1 | $0.6473 | $0.6938 | $0.7437 | +0.14% |
| Jun 2 | $0.6423 | $0.6941 | $0.75 | +0.17% |
| Jun 3 | $0.6378 | $0.6943 | $0.7559 | +0.20% |
| Jun 4 | $0.6336 | $0.6945 | $0.7613 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6336 | $0.6945 | $0.7613 | +0.24% |
| Week 2 | $0.6115 | $0.6962 | $0.7927 | +0.47% |
| Week 3 | $0.5953 | $0.6978 | $0.818 | +0.71% |
| Week 4 | $0.5822 | $0.6995 | $0.8404 | +0.95% |
| Week 5 | $0.5711 | $0.7012 | $0.8608 | +1.19% |
| Week 6 | $0.5613 | $0.7028 | $0.8799 | +1.43% |
| Week 7 | $0.5526 | $0.7045 | $0.8981 | +1.67% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pasithea Therapeutics Corp. is a clinical-stage biotechnology company focusing on discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its symbol is KTTA and its lead development program includes PAS-003 to treat amyotrophic lateral sclerosis and PAS-004, a next-generation MEK inhibitor intended to address a range of RASopathies and MAPK pathway-driven tumors.
The company also plans PAS-001 to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
KTTA is currently priced at $0.6998 with a market cap of $23.38M and a rank of 4899. The stock trades within a 30-day range of $0.5513 to $0.8883, reflecting meaningful near-term volatility. The multi-year forecast shows the average price progressing from $0.6998 in 2026 toward higher levels in later years, with a neutral stance in the near term shifting to bullish in the 2033–2050 window and a max forecast reaching $4.25 by 2050.
A major floor 18.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.7% away) — a key level to hold.
The nearest ceiling, 22.7% above — a clean break opens room to run.
A major ceiling 33.8% above — clearing it would confirm fresh momentum.
Key KTTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KTTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7032 | Sell | $0.7041 | Sell |
| MA 10 | $0.7348 | Sell | $0.7253 | Sell |
| MA 20 | $0.7663 | Sell | $0.7428 | Sell |
| MA 50 | $0.7558 | Sell | $0.7635 | Sell |
| MA 100 | $0.8025 | Sell | $0.7962 | Sell |
| MA 200 | $0.8168 | Sell | $0.9632 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.29 | Neutral |
| Stoch RSI (14) | 11.35 | Buy |
| CCI (20) | -92.66 | Neutral |
| Williams %R (14) | -91.87 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -12.83 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 8.13 | Buy |
| TRIX (15) | -0.04 | Sell |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 23.96 | Buy |
| Momentum (10) | -0.09 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 0.68 | Buy |
| ADX (14) | 16.04 | Neutral |
| ATR (14) | 0.02 | Info |
The near-term technical picture is bearish, with RSI14 at 40 and the price trading below the SMA50 of $0.7613 and the SMA200 of $0.8168. There is support at $0.674 and resistance at $0.85 that frame potential moves. Over the past 30 days KTTA has ranged from $0.5513 to $0.8883, highlighting notable volatility (annualized volatility 70%).
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.674 | $0.6929 | $0.9926 | 0% | Neutral | |
| $0.5945 | $0.7698 | $1.06 | +11% | Neutral | |
| $0.518 | $0.695 | $1.00 | 0% | Neutral | |
| $0.5171 | $0.7149 | $1.07 | +3% | Neutral | |
| $0.4925 | $0.6993 | $1.08 | +1% | Neutral | |
| $0.487 | $0.7087 | $1.12 | +2% | Neutral | |
| $0.5494 | $0.8183 | $1.32 | +18% | Neutral | |
| $0.6128 | $0.9328 | $1.54 | +35% | Bullish | |
| $0.6438 | $1.00 | $1.68 | +44% | Bullish | |
| $0.5949 | $0.9436 | $1.61 | +36% | Bullish | |
| $0.7449 | $1.30 | $2.38 | +87% | Bullish | |
| $0.9753 | $2.00 | $4.08 | +189% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.674 | $0.6929 | $0.8205 | +0.00% |
| June 2026 | $0.6122 | $0.7233 | $0.8778 | +4.38% |
| July 2026 | $0.5984 | $0.7146 | $0.8821 | -1.20% |
| August 2026 | $0.5897 | $0.7101 | $0.888 | -0.62% |
| September 2026 | $0.6153 | $0.7462 | $0.9429 | +5.07% |
| October 2026 | $0.6308 | $0.7699 | $0.9822 | +3.18% |
| November 2026 | $0.6176 | $0.7581 | $0.9752 | -1.53% |
| December 2026 | $0.6204 | $0.7656 | $0.9926 | +0.99% |
Click any year to see its month-by-month KTTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect KTTA to range from $0.674 to $0.9926 through 2026. The $0.6929 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The KTTA price prediction for 2027 points to an average of $0.7698 (low $0.5945, high $1.06) — a potential gain of +11% on today's $0.6929. Price action looks broadly range-bound.
In 2028, KTTA is projected to trade between $0.518 and $1.00, averaging $0.695 — a potential gain of 0% from today's $0.6929. That is -10% versus the projected 2027 average. A consolidation phase looks the most probable path here.
Pasithea Therapeutics Corp.'s 2029 outlook centres on $0.7149, within a $0.5171 to $1.07 range. That is up +3% on the projected 2028 average. That marks a +3% change versus current levels. Price action looks broadly range-bound.
By 2030, KTTA could reach as high as $1.08, with a base case around $0.6993 and support toward $0.4925 — roughly +1% from $0.6929. A consolidation phase looks the most probable path here.
Expect KTTA to range from $0.487 to $1.12 through 2031. The $0.7087 average target implies a +2% move from current prices. That is up +1% on the projected 2030 average. Price action looks broadly range-bound.
The KTTA price prediction for 2032 points to an average of $0.8183 (low $0.5494, high $1.32) — a potential gain of +18% on today's $0.6929. A consolidation phase looks the most probable path here.
In 2033, KTTA is projected to trade between $0.6128 and $1.54, averaging $0.9328 — a potential gain of +35% from today's $0.6929. That is up +14% on the projected 2032 average. Momentum favours further upside here.
Pasithea Therapeutics Corp.'s 2034 outlook centres on $1.00, within a $0.6438 to $1.68 range. That is up +7% on the projected 2033 average. That marks a +44% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, KTTA could reach as high as $1.61, with a base case around $0.9436 and support toward $0.5949 — roughly +36% from $0.6929. Momentum favours further upside here.
Expect KTTA to range from $0.7449 to $2.38 through 2040. The $1.30 average target implies a +87% move from current prices. That is up +37% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The KTTA price prediction for 2050 points to an average of $2.00 (low $0.9753, high $4.08) — a potential gain of +189% on today's $0.6929. Momentum favours further upside here.
Investing $1,000 in KTTA today (≈ 1,443.209698 KTTA) could be worth
$2,893.36
+$1,893.36 (+189%) by 2050 · US Dollar
Based on the average projected KTTA price of $2 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KTTAwould be worth at today's price.
$1,000 invested in KTTA on May 27, 2025 (≈ 1,098.901067 KTTA) would be worth
$761.43
-$238.57 (-23.9%) today · 0.76× · US Dollar
Based on a KTTA entry price of $0.91 vs. today's $0.6929.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.722 | $959.7 | -4.0% |
| 1 month ago | $0.69 | $1,004.2 | +0.4% |
| 3 months ago | $0.838 | $826.85 | -17.3% |
| 6 months ago | $1.47 | $471.36 | -52.9% |
| 1 year ago | $0.91 | $761.43 | -23.9% |
| All time (4.7y) ago | $71.2 | $9.73 | -99.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KTTA forecast.
Our base-case forecast reaches $1.40 around 2050.
Implied market cap at $1.40: $46.78M
Forecasts indicate a neutral bias through 2032, with 2026 showing an average of $0.6998 (min $0.674, max $1.02) and a 0 roiPct. The 2032 forecast lifts the average to $0.8393 with a max of $1.37 and a 19.9 roiPct, followed by a bullish shift in 2033 where the average reaches $0.9508 and the max $1.59 (35.9 roiPct). The path remains bullish into 2040 (average $1.32, max $2.46, 88.4 roiPct) and 2050 (average $2.05, max $4.25, 192.8 roiPct).
These estimates are not guarantees and actual results may vary.
Tap a question to reveal the answer.
2030 – min $0.4908, avg $0.7044, max $1.10, roiPct 0.7, sentiment NEUTRAL.
Forecasts show neutral sentiment through 2032 with a bullish outlook from 2033 onward; current price is $0.6998 and volatility is high (annualized volatility 70%). These figures are estimates and not guarantees.
Yes, the 2050 forecast max is $4.25 with an average of $2.05 and roiPct 192.8 while sentiment is BULLISH.
Low $0.5513, High $0.8883.
Forecast turns BULLISH in 2033, with continued bullish momentum into 2040 and 2050 (2033 average $0.9508, max $1.59; 2040 average $1.32, max $2.46; 2050 average $2.05, max $4.25).
Pasithea Therapeutics Corp. Community Discussion
0Share your Pasithea Therapeutics Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.